ME

Medcom Tech SAMAD Medcom Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

0.026

Micro

Exchange

XMAD - Bolsa de Madrid

MED.MC Stock Analysis

ME

Uncovered

Medcom Tech SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-11/100

Low score

Market cap $B

0.026

Dividend yield

Shares outstanding

12.968 B

Medcom Tech SA engages in the investigation, creation, and marketing of medical products and patented devices. The company is headquartered in Viladecans, Barcelona and currently employs 127 full-time employees. The company went IPO on 2010-03-01. The firm comprises of four departments: Department of Goods, Department of medical professionals, Department of Administration and Logistics and Department of Finance. The product range offered by the Company includes devices treating spine disorders (Dervical, Dorsal of Lumbar pathologies), thousands of patented prosthetic implants for surgery, implants used to synthesize fractures, prosthetic implants for upper limb and foot, as well as medical instruments and precision accessories, among others. The firm also has a license to distribute the patents of such companies as United Ortopedic Corporation, K2M, Bone Support, PAN Medical Ltd, Ranier Technology Ltd, Ascencion Orthopedics and Extremity Medical LLC, among others.

View Section: Eyestock Rating